Sheila Piva

756 total citations
27 papers, 588 citations indexed

About

Sheila Piva is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sheila Piva has authored 27 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Sheila Piva's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sheila Piva is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sheila Piva collaborates with scholars based in Italy, United Kingdom and United States. Sheila Piva's co-authors include L. Beinat, P. Gishen, J Dacre, R. W. Jubb, Gabriella Farina, Nicla La Verde, Anna Moretti, Marina Chiara Garassino, Valter Torri and Mirko Marabese and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Sheila Piva

23 papers receiving 571 citations

Peers

Sheila Piva
Annalisa La Cesa Italy
Yinghua Qi China
C. Moniz United Kingdom
Daniela Niepel Switzerland
Yuko Waguri‐Nagaya Japan
Kristen R. Georgiou Australia
A. John Yates United States
Michael J. Monument Canada
Victoria Borba Brazil
Rebecca Pedersini Italy
Annalisa La Cesa Italy
Sheila Piva
Citations per year, relative to Sheila Piva Sheila Piva (= 1×) peers Annalisa La Cesa

Countries citing papers authored by Sheila Piva

Since Specialization
Citations

This map shows the geographic impact of Sheila Piva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Piva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Piva more than expected).

Fields of papers citing papers by Sheila Piva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Piva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Piva. The network helps show where Sheila Piva may publish in the future.

Co-authorship network of co-authors of Sheila Piva

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Piva. A scholar is included among the top collaborators of Sheila Piva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Piva. Sheila Piva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noci, Sara, Tania Camboni, Eleonora Mangano, et al.. (2025). Regulatory polymorphisms of MSH6, MSH2, FBXO11, and PPP1R21 genes affect survival of patients with immunotherapy-treated lung cancer. Journal for ImmunoTherapy of Cancer. 13(9). e011526–e011526.
2.
3.
Ruggieri, Lorenzo, Anna Moretti, Rossana Berardi, et al.. (2023). Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International Journal of Molecular Sciences. 24(5). 4974–4974. 5 indexed citations
4.
Cona, Maria Silvia, Eliana Rulli, Davide Dalu, et al.. (2021). The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic. Supportive Care in Cancer. 30(2). 1115–1125. 7 indexed citations
5.
Moretti, Anna, F Bianchi, Giorgio Gherardi, et al.. (2018). Localized morphea after breast implant for breast cancer: A case report. Tumori Journal. 104(6). NP25–NP28. 2 indexed citations
6.
Gherardi, Giorgio, Elena Biagioli, Valter Torri, et al.. (2017). The prognostic role of tumor size in early breast cancer in the era of molecular biology. PLoS ONE. 12(12). e0189127–e0189127. 24 indexed citations
7.
Moretti, Anna, et al.. (2017). Does tumor size in T1-T2 early breast cancer (EBC) still have a prognostic role?. Journal of Clinical Oncology. 35(15_suppl). e12087–e12087. 1 indexed citations
8.
Rulli, Eliana, Federica Guffanti, Elisa Caiola, et al.. (2016). The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs. Scientific Reports. 6(1). 39217–39217. 5 indexed citations
9.
Rulli, Eliana, Mirko Marabese, Sheila Piva, et al.. (2016). DNA Repair Gene Polymorphisms in Non-Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Containing Chemotherapy. Tumori Journal. 102(4). 367–375. 4 indexed citations
10.
Ganzinelli, Monica, Eliana Rulli, Elisa Caiola, et al.. (2015). Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). Scientific Reports. 5(1). 16331–16331. 11 indexed citations
11.
Piva, Sheila, Monica Ganzinelli, Marina Chiara Garassino, et al.. (2014). Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer. Current Pharmaceutical Design. 20(24). 3933–3943. 27 indexed citations
12.
13.
Torri, Valter, et al.. (2014). Efficacy of biological agents in metastatic triple-negative breast cancer. Cancer Treatment Reviews. 40(5). 605–613. 39 indexed citations
14.
15.
Verde, Nicla La, Sheila Piva, Monica Ganzinelli, et al.. (2013). Tumor Shrinkage and Improved Quality of Life in a Heavily Pretreated Metastatic Breast Cancer Patient Treated with Eribulin. Future Oncology. 9(11). 1703–1709. 1 indexed citations
16.
Verde, Nicla La, et al.. (2012). Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient. Anti-Cancer Drugs. 23(7). 758–760. 4 indexed citations
17.
Riva, Marco Andrea, Marina Chiara Garassino, Nicla La Verde, et al.. (2011). A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancer. Supportive Care in Cancer. 20(3). 475–481. 5 indexed citations
18.
Bianchi, Antonio, et al.. (2011). Efficacy of biologic agents (BA) in metastatic, triple-negative breast cancer (TNBC): A systematic review.. Journal of Clinical Oncology. 29(15_suppl). e11587–e11587. 1 indexed citations
19.
Piva, Sheila, Michela Cinquini, Antônio Rossi, et al.. (2010). Risk/benefit profile of bevacizumab in metastatic colon cancer: A systematic review and meta-analysis. Digestive and Liver Disease. 43(4). 286–294. 44 indexed citations
20.
Montefusco, Vittorio, Francesca Gay, Francesco Spina, et al.. (2008). Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leukemia & lymphoma. 49(11). 2156–2162. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annalisa La Cesa Breakdown of academic impact, for papers by Yinghua Qi Breakdown of academic impact, for papers by C. Moniz Breakdown of academic impact, for papers by Daniela Niepel Breakdown of academic impact, for papers by Yuko Waguri‐Nagaya Breakdown of academic impact, for papers by Kristen R. Georgiou Breakdown of academic impact, for papers by A. John Yates Breakdown of academic impact, for papers by Michael J. Monument Breakdown of academic impact, for papers by Victoria Borba Breakdown of academic impact, for papers by Rebecca Pedersini
Rankless by CCL
2026